Abstract
The formation and growth of kidney cysts (fluid-filled structures lined by epithelial cells) is the primary pathological abnormality in polycystic kidney disease (PKD). Multiple molecular pathways are disrupted in kidney epithelial precursor cells, which lead to altered planar cell polarity, increased proliferation, and fluid secretion, which together with extracellular matrix remodelling culminates in the formation and growth of cysts. Three-dimensional (3D) in vitro cyst models serve as suitable preclinical models to screen candidate drugs for PKD. Madin–Darby Canine Kidney (MDCK) epithelial cells form polarized monolayers with a fluid-filled lumen when suspended in a collagen gel, and their growth is accelerated with the addition of forskolin, a cyclic adenosine monophosphate (cAMP) agonist. Candidate drugs for PKD can be screened for their ability to modulate growth of forskolin-treated MDCK cysts by measuring and quantifying cyst images acquired at progressive timepoints. In this chapter, we describe the detailed methods for the culture and growth of MDCK cysts in a collagen matrix and a protocol for their use in testing candidate drugs to prevent cyst formation and growth.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Calvet JP (1994) Injury and development in polycystic kidney disease. Curr Opin Nephrol Hypertens 3(3):340–348
Mangoo-Karim R, Uchic M, Lechene C, Grantham JJ (1989) Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP. Proc Natl Acad Sci U S A 86(15):6007–6011
Yang B, Sonawane ND, Zhao D, Somlo S, Verkman AS (2008) Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease. J Am Soc Nephrol 19(7):1300–1310
Ibraghimov-Beskrovnaya O, Bukanov NO (2006) In vitro cystogenesis: the search for drugs antagonizing cyst development. Nephrol Ther 2(Suppl 2):S109–S114
Qiu Z, He J, Shao G, Hu J, Li X, Zhou H, Li M, Yang B (2021) Obacunone retards renal cyst development in autosomal dominant polycystic kidney disease by activating NRF2. Antioxidants (Basel) 11(1):38
Gaush CR, Hard WL, Smith TF (1966) Characterization of an established line of canine kidney cells (MDCK). Proc Soc Exp Biol Med 122(3):931–935
Grantham JJ, Uchic M, Cragoe EJ Jr, Kornhaus J, Grantham JA, Donoso V, Mangoo-Karim R, Evan A, McAteer J (1989) Chemical modification of cell proliferation and fluid secretion in renal cysts. Kidney Int 35(6):1379–1389
Dukes JD, Whitley P, Chalmers AD (2011) The MDCK variety pack: choosing the right strain. BMC Cell Biol 12:43
Wallace DP, Grantham JJ, Sullivan LP (1996) Chloride and fluid secretion by cultured human polycystic kidney cells. Kidney Int 50(4):1327–1336
Neufeld TK, Douglass D, Grant M, Ye M, Silva F, Nadasdy T, Grantham JJ (1992) In vitro formation and expansion of cysts derived from human renal cortex epithelial cells. Kidney Int 41(5):1222–1236
Elberg G, Guruswamy S, Logan CJ, Chen L, Turman MA (2008) Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures. Cell Tissue Res 331(2):495–508
Zhu Y, Teng T, Wang H, Guo H, Du L, Yang B, Yin X, Sun Y (2018) Quercetin inhibits renal cyst growth in vitro and via parenteral injection in a polycystic kidney disease mouse model. Food Funct 9(1):389–396
Lannoy M, Valluru MK, Chang L, Abdela-Ali F, Peters DJM, Streets AJ, Ong ACM (2020) The positive effect of selective prostaglandin E2 receptor EP2 and EP4 blockade on cystogenesis in vitro is counteracted by increased kidney inflammation in vivo. Kidney Int 98(2):404–419
Chandra AN, Saravanabavan S, Rangan GK (2021) Role of DNA-dependent protein kinase in mediating cyst growth in autosomal dominant polycystic kidney disease. Int J Mol Sci 22(19):10512
Li Y, Gao J, Yang X, Li T, Yang B, Aili A (2021) Combination of curcumin and ginkgolide B inhibits cystogenesis by regulating multiple signaling pathways. Mol Med Rep 23(3):195
Zhang JQJ, Saravanabavan S, Cheng KM, Raghubanshi A, Chandra AN, Munt A, Rayner B, Zhang Y, Chau K, Wong ATY, Rangan GK (2021) Long-term dietary nitrate supplementation does not reduce renal cyst growth in experimental autosomal dominant polycystic kidney disease. PLoS One 16(4):e0248400
Zhang JQJ, Saravanabavan S, Rangan GK (2021) Effect of reducing ataxia-telangiectasia mutated (ATM) in experimental autosomal dominant polycystic kidney disease. Cell 10(3):532
Cebotaru L, Liu Q, Yanda MK, Boinot C, Outeda P, Huso DL, Watnick T, Guggino WB, Cebotaru V (2016) Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease. Kidney Int 90(1):90–99
Kibbey MC (1994) Maintenance of the EHS sarcoma and Matrigel preparation. J Tissue Cult Methods 16(3):227–230
Martin-Belmonte F, Yu W, Rodriguez-Fraticelli AE, Ewald AJ, Werb Z, Alonso MA, Mostov K (2008) Cell-polarity dynamics controls the mechanism of lumen formation in epithelial morphogenesis. Curr Biol 18(7):507–513
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671–675
Rowe I, Chiaravalli M, Mannella V, Ulisse V, Quilici G, Pema M, Song XW, Xu H, Mari S, Qian F, Pei Y, Musco G, Boletta A (2013) Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat Med 19(4):488–493
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Saravanabavan, S., Rangan, G.K. (2023). Culture of Three-Dimensional Madin–Darby Canine Kidney (MDCK) Cysts for In Vitro Drug Testing in Polycystic Kidney Disease. In: Hewitson, T.D., Toussaint, N.D., Smith, E.R. (eds) Kidney Research. Methods in Molecular Biology, vol 2664. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3179-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3179-9_10
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3178-2
Online ISBN: 978-1-0716-3179-9
eBook Packages: Springer Protocols